Prakash S. Masand, MD
a:1:{i:0;s:19:"Duke-NUS, Singapore";}
Article
An 8-Week Randomized, Double-Blind Trial Comparing Efficacy, Safety, and Tolerability of 3 Vilazodone Dose-Initiation Strategies Following Switch From SSRIs and SNRIs in Major Depressive Disorder
August 6, 2015
Do patients clinically benefit from a switch from initial antidepressant treatment to vilazodone? How often do they experience adverse events? To answer these questions, the authors of this study...
